Andrew Jamieson

Professor

Advanced Research Centre

University of Glasgow

UK

Andrew Jamieson was born in Glasgow and raised in Strathaven, Scotland. In 2003, he completed a BSc Honours degree, 1st Class, in Chemistry, with Medicinal Chemistry at the University of Glasgow. He subsequently studied for a Ph.D. at the University of Glasgow under the supervision of Dr Andrew Sutherland. The aim of his Ph.D. was to investigate a new substrate directed, palladium-catalysed aza-Claisen rearrangement, and utilise this novel reaction for the synthesis of natural products.

In 2007, he took up a postdoctoral research fellowship with Professor William Lubell at the University of Montreal, Canada. During this time he developed a novel synthetic method with which to systematically scan peptides for secondary structure. His research emphasis was determining the bioactive conformation of the growth hormone secretagogue, GHRP-6, as well as the allosteric modulator of the IL-1 receptor, 101.10, rytvela.

In 2008, he took up a postdoctoral position with Professor Andrew Hamilton FRS at Yale University, USA. While there he worked on the design and synthesis of a novel peptide beta-strand mimetic, before moving with Professor Hamilton in 2009 to the University of Oxford, UK. In August 2010, he was appointed to a lectureship in the Centre for Chemical Biology in the Department of Chemistry at the University of Leicester, UK. In 2016 AJ moved to the University of Glasgow as a Senior lecturer, was promoted to Reader in 2019 and to Professor in August 2022. He leads a research group, currently funded by EPSRC, MRC and DTRA, focused on the design and synthesis of chemical tools that can be used to probe the biological mechanisms underpinning disease.